DEF 14C

DEF 14C Filing

Company: ENDONOVO THERAPEUTICS, INC.
Filed: November 14, 2019
Period of Report: November 14, 2019
Accession Number: 0001493152-19-017257

View Document ↗ View on SEC.gov ↗